29 April 2014 | |||||||||
09:00 - 10:30 | RA challenges in the biologic era | Sjögren's | Partnerships in primary care | International challenges | Physical activity in OA | Education oral abstracts | Osteoporosis SIG | BHPR CTD SIG | |
10:30 - 11:30 | Coffee, exhibition, poster viewing and Innovation theatre: Roche Products Ltd and Chugai Pharma UK Ltd | ||||||||
11:30 - 13:00 | Flare in RA | Biosimilars in perspective | Primary care - oral abstracts | Thirty years of BSR | Public & patient involvement | OA and Bone oral abstracts | Myositis SIG | Polymyalgia SIG | |
13:00 - 14:15 | Lunch and Innovation theatre: AbbVie Ltd | BSR Biologics Registers meeting | PHD student networking | ||||||
14:15 - 16:15 | Jewels in the Crown | ||||||||
16.15 - 16.45 | Coffee and exhibition | ||||||||
16.45 - 17.45 | Heberden round | ||||||||
17.45 - 19:45 | Industry supported symposium - MSD | Industry supported symposium - Bristol Myers Squibb | |||||||
19:45 - 22:00 | 30th Anniversary dinner and Presidents' reception |
30 April 2014 | |||||||||||||
07.00 - 09.00 | Industry supported symposium - Janssen | Industry supported symposium - A.Menarini Farmaceutica Internazionale SRL | |||||||||||
09:00 - 10:30 | Fibro- myalgia | Mgmt of difficult Lupus | Essentials: Disease mgmt | Fatigue | Tropical medicine 1 | SpA SIG | Rheumatoid arthritis oral abstracts | ||||||
10:30 - 11:30 | Coffee, exhibition, poster viewing and Innovation Sessions: Celgene | ||||||||||||
11:30 - 13:00 | OA therapeutics | SpA update | Essentials: Managing symptoms & patients | BHPR oral abstracts | Tropical medicine 2 | Inflammatory arthritis and comorbidities oral abstracts | Sjögren’s syndrome SIG | Musculoskeletal pain SIG | |||||
13:00 - 14:30 | Lunch and Innovation Sessions: UCB, Janssen | BSR/BHPR AGM | |||||||||||
14:30 - 16:00 | Pain (CRPS) | Lung in RA | Essentials: Clinical decision making | Back pain | Tropical medicine 3 | ARMA MSK clinical networks | BHPR MSK SIG | Osteoarthritis SIG | |||||
16.00 - 16.30 | Coffee and exhibition | ||||||||||||
16.30 - 17.30 | Heberden Oration | ||||||||||||
17:45 - 19:30 | Industry supported symposium: Roche Products Ltd and Chugai Pharma UK Ltd | Industry supported symposium: AbbVie Ltd |